Australia markets closed

Roivant Sciences Ltd. (87S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.77+0.14 (+1.47%)
At close: 03:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
4,466,424
-1,009,030
-845,262
-809,234
Depreciation & amortisation
22,764
18,857
5,932
-
Stock-based compensation
178,180
217,781
564,956
84,958
Change in working capital
24,262
6,345
15,719
71,938
Accounts payable
-7,814
4,359
15,403
3,752
Other working capital
-838,554
-856,083
-695,165
-557,944
Other non-cash items
-79,599
37,548
82,756
398,346
Net cash provided by operating activities
-835,899
-843,393
-677,729
-552,138
Cash flows from investing activities
Investments in property, plant and equipment
-2,655
-12,690
-17,436
-5,806
Acquisitions, net
-83,679
-6,706
-39
-
Sales/maturities of investments
-
0
320,170
0
Other investing activities
5,234,521
-139,434
600
-25,896
Net cash used for investing activities
5,310,248
-44,269
303,295
-31,702
Cash flows from financing activities
Debt repayment
-31,076
-30,144
-21,590
0
Common stock issued
655,801
379,708
0
455,756
Other financing activities
-16,581
-13,131
291,570
508
Net cash used provided by (used for) financing activities
662,320
499,462
306,792
456,264
Net change in cash
5,144,421
-381,919
-67,642
-127,576
Cash at beginning of period
1,541,037
2,074,034
2,141,676
2,269,252
Cash at end of period
6,677,706
1,692,115
2,074,034
2,141,676
Free cash flow
Operating cash flow
-835,899
-843,393
-677,729
-552,138
Capital expenditure
-2,655
-12,690
-17,436
-5,806
Free cash flow
-838,554
-856,083
-695,165
-557,944